Invests in Armonica Technologies, inc.


Armonica Technologies, inc.

We participated in the Series B funding of Armonica technologies, inc. which is developing a next-generation sequencer using optical technology. Armonica's approach will lead to faster, more thorough and more accurate genomic analysis than is currently available, without the need for extensive workflow and reagents. By investing in Armonica's technology we hope to speed the development of new and more effective treatments to some of the world's most devastating diseases."

Contact us to learn more about CVC.